Fall Into Safety
Welcome to The Science Behind Workplace Injuries: Fall Safety Series, where we explore how seasonal conditions interact with human physiology, behavior, and workplace systems. Yesterday, we examined how workplaces can become transmission systems for respiratory viruses. Autumn brings another respiratory shift as ragweed begins to decline and outdoor mold spores remain active in decaying leaves, crop residue, compost, and other organic material.
The transition is gradual and regional. Ragweed and mold overlap during early fall, while outdoor mold can remain present after the first frost and decline substantially once snow covers vegetation. For workers with allergic rhinitis, the changing allergen matters. For workplace safety, however, the more consequential question may be what happens after symptoms begin—and what workers take to control them. The research does not establish that autumn mold exposure causes workplace injuries. The evidence points instead toward impaired vigilance from allergy symptoms and, more significantly, impairment associated with some common allergy medications.
Allergy Symptoms Affect More than the Nose
Allergic rhinitis produces inflammation, congestion, sneezing, watery eyes, and other familiar symptoms. Cognitive effects are less visible. Jeffrey Wilken, Robert Berkowitz, and Robert Kane exposed adults with seasonal allergic rhinitis to ragweed under controlled conditions and compared their performance with asymptomatic participants. Symptomatic participants showed reduced vigilance, longer response times, and decreased efficiency in working memory, psychomotor speed, reasoning, and divided attention. The allergen in the experiment was ragweed, so the findings should not be presented as mold-specific, but the study demonstrates that untreated allergic rhinitis can affect cognitive performance.
Sleep adds another pathway. Nasal congestion increases airway resistance and can fragment sleep even when total sleep time remains relatively normal. A 2020 systematic review and meta-analysis found allergic rhinitis associated with poorer sleep quality and greater daytime sleepiness, although the authors rated the underlying evidence as low to very low quality. A worker may therefore begin the day carrying both active symptoms and the effects of disrupted sleep.
The Medication May Create the Greater Safety Problem
First-generation antihistamines such as diphenhydramine cross the blood-brain barrier and interfere with histamine’s role in wakefulness. The resulting impairment can affect reaction time, divided attention, coordination, and alertness. The distinction matters because many workers encounter diphenhydramine in familiar over-the-counter allergy, cold, sleep, and “PM” products.
John Weiler and colleagues demonstrated the magnitude of the effect in a randomized crossover trial conducted in the University of Iowa Driving Simulator. Forty licensed drivers received fexofenadine, diphenhydramine, alcohol producing approximately a 0.1% blood alcohol concentration, or placebo before driving for an hour. Driving performance was poorest after diphenhydramine. Participants performed similarly after fexofenadine and placebo.
The behavioral finding may be even more useful for safety professionals: participants could not reliably recognize their own impairment. Self-reported drowsiness did not predict poor driving coherence and was only weakly associated with several other performance measures. Feeling alert therefore did not mean the driver was performing normally. A safety-sensitive worker using a sedating antihistamine may sincerely report feeling fine while experiencing measurable impairment.
Real-world occupational data point in the same direction. Timothy Gilmore and colleagues examined pharmacy records for 3,394 workers diagnosed with occupational injuries and matched controls. Antihistamine users had approximately 1.5 times the odds of occupational injury, although the observational design cannot establish whether medication itself caused the injuries. A later Wisconsin study by Lawrence Hanrahan and L. Clark Paramore examined workers’ compensation applicants and found sedating-antihistamine exposure associated with higher odds of acute traumatic injury. The study evaluated pollen exposure rather than mold, another reason to keep the autumn-mold connection appropriately narrow.
Mold Becomes a Different Hazard at Occupational Doses
Seasonal allergy is only one piece of autumn mold exposure. Agriculture, grain handling, landscaping, composting, mold remediation, demolition, and disaster cleanup can generate concentrations far beyond ordinary environmental exposure. Moldy hay, grain, silage, compost, and other organic material can release enormous quantities of spores and organic dust when disturbed.
Heavy exposure can produce organic dust toxic syndrome (ODTS), an inflammatory illness that can cause fever, cough, chills, muscle aches, and shortness of breath several hours after exposure. Repeated occupational exposure can also contribute to hypersensitivity pneumonitis, including farmer’s lung, an immune-mediated disease capable of causing chronic lung damage. Neither condition requires the worker to have a conventional mold allergy. OSHA estimates approximately one in ten agricultural workers will experience an episode of ODTS.
The distinction changes prevention. Outdoor seasonal allergies may call for symptom management and careful medication selection. Task-generated mold and organic dust require exposure controls: keeping stored crops and building materials dry, controlling dust at the source, using ventilation or filtered equipment cabs, minimizing unnecessary disturbance of contaminated material, and providing appropriate respiratory protection when exposure requires it. Moisture control remains one of the most effective ways to prevent occupational mold problems before spores become airborne.
Safety Policies Should Account for What Workers Take
Many organizations have detailed policies addressing alcohol, illicit drugs, fatigue, and prescription medications while saying little about over-the-counter products. The label “over the counter” describes availability, not the absence of performance effects. Safety-sensitive jobs deserve specific attention because driving, operating machinery, working at height, and responding to rapidly changing hazards depend heavily on vigilance and reaction time.
The evidence also argues against telling workers simply to endure allergy symptoms. Untreated allergic rhinitis can impair vigilance, while second-generation antihistamines such as fexofenadine have demonstrated substantially less cognitive and psychomotor impairment than first-generation medications. Medication decisions belong between workers and appropriate health professionals, but employers can educate employees about sedation warnings, encourage workers to review active ingredients, and create a confidential process for discussing fitness for safety-sensitive work.
Workers’ compensation data will rarely reveal the medication connection. A fall, collision, or machine injury is coded according to the event and resulting injury. The antihistamine taken the previous evening may never appear in the claim record. Occupational respiratory disease can be similarly underrepresented: Michigan surveillance spanning 31 years found that 51% of confirmed work-related asthma cases never applied for workers’ compensation benefits.
Autumn changes the allergen environment, but exposure alone tells only part of the safety story. Symptoms can affect vigilance. Treatment can introduce additional impairment. High occupational doses can produce respiratory disease far beyond ordinary seasonal allergies. When impairment is difficult for people to perceive in themselves, prevention has to rely on better information and better system design.
Tomorrow in The Science Behind Workplace Injuries: Fall Safety Series — Indoor Air Quality as Buildings Close Up. As windows close and heating systems return to service, ventilation, moisture, filtration, carbon dioxide, and indoor contaminants begin shaping another part of the fall workplace environment.
Research Referenced
Gilmore, T. M., Alexander, B. H., Mueller, B. A., & Rivara, F. P. (1996). Occupational injuries and medication use. American Journal of Industrial Medicine, 30(2), 234–239. doi:10.1002/(SICI)1097-0274(199608)30:2<234::AID-AJIM16>3.0.CO;2-Y
Hanrahan, L. P., & Paramore, L. C. (2003). Aeroallergens, allergic rhinitis, and sedating antihistamines: Risk factors for traumatic occupational injury and economic impact. American Journal of Industrial Medicine, 44(4), 438–446. doi:10.1002/ajim.10285
Weiler, J. M., Bloomfield, J. R., Woodworth, G. G., Grant, A. R., Layton, T. A., Brown, T. L., McKenzie, D. R., Baker, T. W., & Watson, G. S. (2000). Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: A randomized, placebo-controlled trial in the Iowa Driving Simulator. Annals of Internal Medicine, 132(5), 354–363. doi:10.7326/0003-4819-132-5-200003070-00004
Wilken, J. A., Berkowitz, R., & Kane, R. (2002). Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis. Annals of Allergy, Asthma & Immunology, 89(4), 372–380. doi:10.1016/S1081-1206(10)62038-8
